Johnson & Johnson
(JNJ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,865,000 | 12,889,000 | 11,355,000 | 10,983,000 | 10,463,000 |
| Marketable Securities | 5,443,000 | 9,392,000 | 22,724,000 | 21,585,000 | 19,925,000 |
| Receivables | 16,350,000 | 14,039,000 | 15,890,000 | 16,139,000 | 15,594,000 |
| Inventories | 12,809,000 | 10,268,000 | 11,675,000 | 11,437,000 | 10,990,000 |
| Other current assets | 0 | 5,830,000 | 0 | 0 | 0 |
| TOTAL | $64,388,000 | $55,294,000 | $65,236,000 | $63,847,000 | $60,424,000 |
| Non-Current Assets | |||||
| PPE Net | 20,174,000 | 17,982,000 | 18,152,000 | 18,354,000 | 18,701,000 |
| Intangibles | 93,023,000 | 74,536,000 | 73,719,000 | 76,574,000 | 79,355,000 |
| Other Non-Current Assets | 18,384,000 | 39,566,000 | 18,017,000 | 18,949,000 | 19,875,000 |
| TOTAL | $131,581,000 | $132,084,000 | $109,888,000 | $113,877,000 | $117,931,000 |
| Total Assets | $195,969,000 | $187,378,000 | $175,124,000 | $177,724,000 | $178,355,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,909,000 | 9,889,000 | 10,153,000 | 9,765,000 | 9,309,000 |
| Accrued Expenses | 28,219,000 | 27,347,000 | 28,980,000 | 28,771,000 | 28,076,000 |
| TOTAL | $60,373,000 | $55,802,000 | $45,543,000 | $44,821,000 | $43,390,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 34,928,000 | 26,886,000 | 27,603,000 | 28,292,000 | 28,851,000 |
| Other Non-Current Liabilities | 25,382,000 | 23,895,000 | 22,433,000 | 23,239,000 | 24,981,000 |
| TOTAL | $64,727,000 | $54,772,000 | $54,982,000 | $56,546,000 | $60,256,000 |
| Total Liabilities | $125,100,000 | $110,574,000 | $100,525,000 | $101,367,000 | $103,646,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,598,734 | 2,604,286 | 2,614,484 | 2,629,180 | 2,631,402 |
| Common Shares | 3,120,000 | 3,120,000 | 3,120,000 | 3,120,000 | 3,120,000 |
| Retained earnings | 124,558,000 | 128,345,000 | 127,917,000 | 126,216,000 | 124,380,000 |
| Other shareholders' equity | -12,626,000 | -12,967,000 | -15,292,000 | -13,843,000 | -13,757,000 |
| TOTAL | $70,869,000 | $76,804,000 | $74,599,000 | $76,357,000 | $74,709,000 |
| Total Liabilities And Equity | $195,969,000 | $187,378,000 | $175,124,000 | $177,724,000 | $178,355,000 |